“COVID-19 Toe” and Underrepresentation in People of Color: Is Racial Bias to Blame?
The association of COVID-19 and chilblains in patients with skin of color was evaluated.
The association of COVID-19 and chilblains in patients with skin of color was evaluated.
A machine learning-based mobile phone app may serve as a diagnostic support tool for a range of common skin conditions in patients of color.
Factors associated with delays in treatment for patients with Merkel cell carcinoma were investigated.
The efficacy of 2 sessions of a mixture of transforming growth factor beta (TGF-β), granulocyte-monocyte colony-stimulating factor, and platelet-derived growth factor to address anti-aging and promote skin rejuvenation was examined.
Among people with skin of color, ultraviolet (UV) exposure may not be an important risk factor for melanoma.
The association between metformin and keratinocyte carcinoma in high-risk patients was evaluated.
The expressed research and clinical interests of current US dermatology residents was examined.
Racial/ethnic concordance between patients and their physicians is associated with higher patient satisfaction scores.
The efficacy and safety of single-agent chemical peels in patients with pigmented skin, was investigated via a systematic review and meta-analysis of the current literature.
A roundtable discussion by experts in issues facing patients with skin of color reveals interesting insights.